As the ASX200 traded flat today, with Real Estate leading gains and Energy lagging behind, investors are closely monitoring sector performances to identify potential opportunities. In this environment, finding stocks that may be trading below their estimated value can offer a strategic advantage for those looking to capitalize on market inefficiencies. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) PointsBet Holdings (ASX:PBH) A$1.26 A$2.05 38.4% Kogan.com (ASX:KGN) A$3.99 A$7.77 48.6% Kinatico (ASX:KYP) A$0.265 A$0.46 42.1% Integral Diagnostics (ASX:IDX) A$2.94 A$5.87 49.9% Elders (ASX:ELD) A$7.40 A$14.04 47.3% Credit Clear (ASX:CCR) A$0.255 A$0.47 45.8% Collins Foods (ASX:CKF) A$9.69 A$16.13 39.9% Austal (ASX:ASB) A$6.75 A$13.22 48.9% Atturra (ASX:ATA) A$0.77 A$1.24 37.8% Advanced Braking Technology (ASX:ABV) A$0.099 A$0.16 39% Click here to see the full list of 34 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Integral Diagnostics Overview: Integral Diagnostics Limited is a healthcare services company that offers diagnostic imaging services to medical professionals and their patients in Australia and New Zealand, with a market cap of A$1.09 billion. Operations: The company generates revenue of A$627.22 million from the operation of diagnostic imaging facilities across Australia and New Zealand. Estimated Discount To Fair Value: 49.9% Integral Diagnostics appears undervalued, trading at A$2.94, significantly below its estimated fair value of A$5.87. Despite recent shareholder dilution and low forecasted return on equity, the company has become profitable with net income of A$4.67 million for the year ending June 2025, compared to a loss previously. Earnings are expected to grow significantly at 31.23% annually, outpacing both revenue growth and market averages in Australia, highlighting potential for cash flow-driven valuation appreciation. The analysis detailed in our Integral Diagnostics growth report hints at robust future financial performance. Unlock comprehensive insights into our analysis of Integral Diagnostics stock in this financial health report.ASX:IDX Discounted Cash Flow as at Aug 2025 IDP Education Overview: IDP Education Limited facilitates student placements into educational institutions across Australia, the United Kingdom, the United States, Canada, New Zealand, and Ireland with a market cap of A$1.64 billion. Operations: The company's revenue segments include facilitating student placements into educational institutions across Australia, the United Kingdom, the United States, Canada, New Zealand, and Ireland. Story Continues Estimated Discount To Fair Value: 31.2% IDP Education is trading at A$5.89, below its estimated fair value of A$8.56, presenting a potential undervaluation based on cash flows. Despite recent earnings decline, with net income dropping to A$44.51 million for the year ending June 2025 from A$132.75 million previously, earnings are forecast to grow at 24.51% annually over the next three years, outpacing market averages in Australia and suggesting room for valuation improvement driven by expected profit growth. According our earnings growth report, there's an indication that IDP Education might be ready to expand. Take a closer look at IDP Education's balance sheet health here in our report.ASX:IEL Discounted Cash Flow as at Aug 2025 Tabcorp Holdings Overview: Tabcorp Holdings Limited operates in Australia, offering gambling, entertainment, and integrity services with a market capitalization of A$2.20 billion. Operations: Tabcorp's revenue is primarily derived from its Wagering and Media segment, which generated A$2.44 billion, complemented by A$175.80 million from Integrity Services. Estimated Discount To Fair Value: 31.9% Tabcorp Holdings is trading at A$0.97, below its estimated fair value of A$1.42, highlighting potential undervaluation based on cash flows. The company recently turned profitable with a net income of A$36.6 million for the fiscal year ending June 2025, compared to a significant net loss the previous year. Earnings are projected to grow at 24% annually over the next three years, surpassing market averages in Australia and indicating potential for valuation enhancement through profit growth. Insights from our recent growth report point to a promising forecast for Tabcorp Holdings' business outlook. Click to explore a detailed breakdown of our findings in Tabcorp Holdings' balance sheet health report.ASX:TAH Discounted Cash Flow as at Aug 2025 Make It Happen Delve into our full catalog of 34 Undervalued ASX Stocks Based On Cash Flows here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:IDX ASX:IEL and ASX:TAH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Stocks Including Integral Diagnostics That May Be Trading Below Estimated Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...